ClinicalTrials.gg
Drug

Sparsentan clinical trials

Also written RE-021 and PS433540.

studies test it
12
open now
3
in phase 3
2
first study started
2007

How each study uses sparsentan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sparsentan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Feb 2023 · FILSPARI · NDA 216403 (FDA, Drugs@FDA)
European Union
19 Apr 2024 · Filspari · EMEA/H/C/005783 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sparsentan
9

Brand

Filspari
1

Development codes

RE-021
5
PS433540
2

Studies by the year they started

12 studies that test it; most in 2018 (2)

Studies that test sparsentan, by start year
YearStudies
20071
20081
20141
20182
20202
20211
20221
20231
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
7
Phase 3
2
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 3

Travere Therapeutics, Inc. (7) · Ligand Pharmaceuticals (2) · University of Edinburgh (1) · Brigham and Women's Hospital (1) · University of Leicester (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test sparsentan.

Studies

Open first, then newest update. How each study uses sparsentan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Codes

What other systems call sparsentan · ClinicalTrials.gg INT001171

  • MeSH (NLM) C000634424sparsentanConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 9242RO5URMSPARSENTANConfirmed FDA, NLM, Wikidata
  • Wikidata Q27088845sparsentanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152412SparsentanOne source FDA
  • DrugBank DB12548One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.